基本信息
姓名: 应杰儿 性别: 女
学历: 本科 学位: 博士(硕导)
职称: 主任医师 出生年份: 1973
博导类型: 博导专业: —— 博导学院: ——
硕导类型: 学术型 硕导专业: 肿瘤学 硕导学院: 第二临床医学院
Email: 联系电话:
研究方向:
工作单位: 附属肿瘤医院
发表论文
1、RhoAE-cadherin expression in gastric cancer patients correlations with clinicopathological features and prognosis,Qi Xu,Jieer Ying,INT J CLIN EXP MED,SCI,2019-12,Zhejiang Cancer Hospital,4区,0.181,13757-13764

---

2、The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis,Jieer Ying,Hongming Pan,Onco Targets Ther,SCI,2015-08,Zhejiang University,3区,2.612,2427-33

---

3、Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer,Qiong He,Jieer Ying,Onco Targets Ther,SCI,2016-04,Zhejiang Cancer Hospital,3区,2.612,2329-35

---

4、Prognostic value of p53 for colorectal cancer after surgical resection of pulmonary metastases,Cong Li,Jieer Ying,World J Surg Oncol,SCI,2016-12,Zhejiang Cancer Hospital,4区,1.6,308

---

5、NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population,Xiaoying Chen,Jieer Ying,Oncotarget,SCI,2017-07-31 00:00,Ningbo University,3区,5.1651,8105-8119

---

6、C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases,Cong Li,Jieer Ying,Bull Cancer,SCI,2017-03-01 00:00,Zhejiang Cancer Hospital,4区,0.853,232-236

---

7、Prognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection,Yinbo Chen,Jieer Ying,Oncotarget,SCI,2017-08,Zhejiang Cancer Hospital,3区,5.1651,70841-70846

---

8、The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer,Haochang Hu,Jieer Ying,Oncotarget,SCI,2017-09,Ningbo University,3区,5.1651,84054-84065

---

9、Endothelial PAS domain protein 1 gene hypomethylation is associated with colorectal cancer in Han Chinese,Ranran Pan,Jieer Ying,Exp Ther Med,SCI,2018-12-01 00:00,Ningbo University,4区,1.41,4983-4990

---

10、全身化疗在直肠癌(新)辅助治疗中的最新进展——从内科的角度看,应杰儿,应杰儿,浙江医学,-,2019-01,浙江省肿瘤医院,-,0.53,107-111

---

11、晚期原发性肝癌内科治疗进展,徐 琦,应杰儿,中国肿瘤,中文核心期刊(2017),2019-02-11 00:00,浙江省肿瘤医院,-,0.802,373-380

---

12、The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study,Luxi Yin,Jieer Ying,Medicine (Baltimore),SCI,2018-12-01 00:00,Zhejiang Cancer Hospital,4区,2.028,e13570

---

科研项目
1、PDTX模型联合NGS探究难治性胃肠道肿瘤治疗新策略,应杰儿,浙江省肿瘤医院,浙江省科技厅,浙江省公益技术应用研究实验动物计划项目,2017-01,2020-12,6,0

---

2、胃癌“形神并重 瘀毒 郁同治”临床方案的创新研究与应用,张光霁,浙江中医药大学,国家科学技术部,国家重点研发计划项目,2019-12,2021-12,20,0

---

科研成果
1、,,,,,,

---

个人信息
浙江大学肿瘤学博士，主任医师，病区主任。美国宾夕法尼亚大学访问****。研究方向为腹部肿瘤（胃癌、结直肠癌、间质瘤以及肝胆胰等腹部肿瘤）的临床诊治及科研工作。以第一或通讯作者发表文章30余篇，SCI文章20余篇；主持浙江省级基金多项；参与数十项消化道肿瘤新药的Ⅱ、Ⅲ期临床研究。研究成果多次在国际性大会中交流。在一系列国家级及省级学会任职，包括中国抗癌协会肠癌专委会、靶向治疗专委会委员、中国医师协会外科医师分会 MDT专委会委员、CSCO结直肠癌专家委员会委员、CSCO胃癌专家委员会委员、CSCO肝癌专家委员会委员、CSCO胆管癌专家委员会委员、浙江省抗癌协会转移专委会候任主委、浙江省医学会肿瘤营养与治疗学分会委员会副主任委员、浙江省医师协会肿瘤精准治疗专业委员会副主任委员、浙江省抗癌协会肿瘤内科专业委员会常务委员等。2013年浙江省“医坛新秀”,浙江省肿瘤医院1022中青年创新性人才。